北米初の医学的監督を受けた安全な注射施設の開設後,過剰摂取による死亡率の減少:人口をベースとした遡及的な研究
Brandon D L Marshall1, M-J Milloy, Evan Wood
1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
Lancet (London, England)
|April 19, 2011
まとめ
バンクーバーで注射管理施設 (SIF) の開設は,致命的な過剰摂取率の有意な減少と関連していました. この公衆衛生の介入は,薬物関連死亡率を低減する有望な見通しを示しています.
科学分野:
- 公衆衛生は公衆衛生である.
- エピデミオロジー エピデミオロジー
- 依存症医学 薬物中毒医学
背景:
- 違法薬物過剰摂取は,北米で予防可能な死亡の主な原因です.
- 薬物使用による害を軽減するために,世界的に注射施設 (SIF) が設置されています.
- この研究では,バンクーバーのSIFが過剰摂取による死亡率に与える影響を調査しています.
研究 の 目的:
- カナダのバンクーバーに監督注射施設 (SIF) の設置が,過剰摂取による死亡率の減少と相関するかどうかを調べた.
- SIFの開設前と後に,過剰摂取による死亡率を分析する.
主な方法:
- 2001年1月1日から2005年12月31日までの人口ベースの過剰摂取による死亡率データを調査した.
- SIF周辺の500m半径の死亡率と,バンクーバーの残りの部分の死亡率を比較した.
- 死亡の場所を決定するために,地方検死官の記録からデータを利用しました.
主要な成果:
- SIFの500m以内の致死性過剰投与率は,開封後35%減少した (人年10万人に253.8から165.1).
- 対照的に,市内の他の地域では,同期間に致死性過剰摂取率が9.3%減少しただけであった.
- SIFの存在と過剰摂取率の変化の間の有意な相互作用が観察されました (p=0.049).
結論:
- 監督注射施設 (SIF) は,注射薬物使用率が高い地域では,貴重な公衆衛生のツールです.
- SIFは,人口密度の高い都市部で過剰摂取による死亡を減らすのに特に有効である可能性があります.
- 結論は,SIFを害を軽減する戦略の一部として考慮することを支持しています.
関連する概念動画
Prevention of Further Absorption of Poison
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...


